In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing…
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences…
In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing…
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences…
In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing…
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences…
Jeff recently spoke with Pulitzer-prize winning journalist Kathleen Gallagher on her podcast “How Did You Do That?”, discussing his expansive career in life sciences…
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on…
Jeff recently spoke with Pulitzer-prize winning journalist Kathleen Gallagher on her podcast “How Did You Do That?”, discussing his expansive career in life sciences…
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on…
